About PROGEN
PROGEN provides high-quality analytical tools for gene therapy and life sciences professionals.
By delivering robust and reliable viral and non-viral gene therapy tools, antibodies, proteins, and kits to scientists worldwide, we empower researchers in academia, biotech, and pharmaceutical industries and commercial manufacturers to advance scientific discovery and develop breakthrough therapies.
Founded in 1983, PROGEN is one of Germany’s first biotech companies. We collaborate with gene therapy experts worldwide to design innovative solutions that help scientists overcome research, analytical, and manufacturing challenges.
Beyond supplying products, we partner with our customers to understand their unique needs and provide specialized support throughout their research journey.
Making gene therapy better. Together.
USPs
We are more than just a manufacturer of antibodies, AAV gene therapy tools, density gradient media and phage display technologies.
We strive to understand what scientists need, so we can create solutions and ultimately deliver high quality antibody and exclusive AAV products,which solve research challenges within academia, biotech and pharma.
For our customers and partners, we ensure support throughout the whole process – from inquiry to application support – so we can continue to be a trusted and reliable partner.
Sectors
- antibodies
- in vitro reagents
- proteins
- molecular